Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD).

Author: SeligmanStephen J

Paper Details 
Original Abstract of the Article :
Although previously considered as the safest of the live virus vaccines, reports published since 2001 indicate that live yellow fever virus vaccine can cause a severe, often fatal, multisystemic illness, yellow fever vaccine-associated viscerotropic disease (YEL-AVD), that resembles the disease it w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.vaccine.2014.08.051

データ提供:米国国立医学図書館(NLM)

Yellow Fever Vaccine: A Rare but Serious Risk

This research examines the potential risks associated with the yellow fever vaccine, a vaccine widely regarded as safe and effective. The authors explore the phenomenon of yellow fever vaccine-associated viscerotropic disease (YEL-AVD), a rare but potentially fatal complication that can resemble the disease the vaccine is intended to prevent. The study analyzes data on YEL-AVD cases, identifying risk groups based on factors such as age, gender, and underlying health conditions. The research highlights the importance of recognizing YEL-AVD as a potential complication and emphasizes the need for further investigation to understand the underlying mechanisms and develop strategies to minimize the risk.

A Sandstorm of Risk: Yellow Fever Vaccine and YEL-AVD

The study reveals that the yellow fever vaccine, while generally considered safe, carries a rare but serious risk of YEL-AVD. The analysis of YEL-AVD cases identifies specific risk groups, emphasizing the need for careful consideration and monitoring in vulnerable populations. This research underscores the importance of ongoing vigilance and research to ensure the safety and effectiveness of vaccines.

Navigating the Sands of Vaccine Safety

Navigating the sands of vaccine safety requires a careful balance between the benefits and risks of immunization. This research highlights the importance of understanding the potential risks, even those that are rare. Open communication with your healthcare provider is crucial to ensure that you receive the appropriate vaccinations and are aware of any potential complications. Remember, the desert of vaccine safety is best navigated with a watchful eye and informed decision-making.

Dr.Camel's Conclusion

The yellow fever vaccine, while generally considered safe and effective, carries a rare but potentially serious risk of YEL-AVD. This research highlights the importance of ongoing vigilance and research to ensure the safety and effectiveness of vaccines, reminding us that even in the vast desert of medical knowledge, there are always new sands to explore.

Date :
  1. Date Completed 2015-04-06
  2. Date Revised 2014-09-26
Further Info :

Pubmed ID

25192973

DOI: Digital Object Identifier

10.1016/j.vaccine.2014.08.051

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.